3 results
To demonstrate that treatment with drotrecogin alfa (activated) 24 mcg/kg/h administered as an intravenous infusion for 96 hours reduces 28 day all-cause mortality in adult patients with septic shock compared with placebo.
To reduce stress-related problems and increases reintegration of work, the company Letec developed a technique that utilizes the light therapy / magnetic therapy treatment platform Xentix besides coaching. In order to demonstrate the effectiveness…
Aim of this proof of principle study is to develop a reliable and safe application of bilateral FES of the calf muscles to facilitate insufficient push-off in patients with MS and to assess the preliminary effects of FES on net ankle power…